There is also evidence suggesting that ASS1 is a tumor suppressor through the ability of ASS1 to promote p53 activity (Lim et al, 2024), or activate an ER stress response independent of its role as a metabolic enzyme (Kim et al, 2021). The gene discussed is TP53; the disease is neoplasm.